Oclacitinib Maleate

Inquire About This Product Request Custom Analogue
Oclacitinib Maleate structure
Structural Feature
Pyrrolopyrimidine scaffold
Reactive Feature
Maleate salt Sulfonamide
Synthesis Role
JAK inhibitor
Application Context
Active pharmaceutical molecule
CAS Number1208319-27-0
Product CodeSL1113017
Molecular FormulaC19H27N5O6S
Molecular Weight453.5
AppearanceWhite to off-white solid
Melting Point135 - 137°C
SMILESCNS(=O)(=O)CC1CCC(N(C)c2ncnc3[nH]ccc23)CC1.O=C(O)C=CC(=O)O
InChIKeyVQIGDTLRBSNOBV-BTJKTKAUSA-N
DescriptionOclacitinib maleate, a JAK1-selective inhibitor. Used for canine atopic dermatitis by inhibiting JAK1 signaling to reduce inflammation.
ApplicationsAPI; JAK inhibitor; veterinary drug

Related Chemicals

2,4-Dichloro-7H-pyrrolo[2,3-d]pyriMidine structure
SL1113010
2,4-Dichloro-7H-pyrrolo[2,3-d]pyriMidine
CAS 90213-66-4
Pyrrolopyrimidine scaffold Dichloro heteroarene Heteroaryl functionalization precursor Pharmaceutical intermediate
2-(Oxetan-3-yl)ethan-1-ol structure
SL1112027
2-(Oxetan-3-yl)ethan-1-ol
CAS 251922-46-0
Oxetane scaffold Alcohol Oxygenated small-ring building block Pharmaceutical intermediate
3-Bromo-5-chloro-4-hydroxyaniline structure
SL1113013
3-Bromo-5-chloro-4-hydroxyaniline
CAS 1158322-54-3
Halogenated aminophenol Aromatic amine Halogenated arylamine building block Pharmaceutical intermediate
1-Tert-butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate structure
SL1112028
1-Tert-butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate
CAS 1884303-05-2
Azetidine scaffold Boc-protected amine Protected heterocyclic intermediate Pharmaceutical intermediate